Skip to content
10-K

Annual Report

Bone Biologics Corp BBLG BBLGW

0001493152-26-008564

← back to feed
Filed
Mar 2, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 23, 2026 1.8M sh
Shares Diluted FY 2025 · Dec 31, 2025 1.17M sh
Shares Diluted restated FY 2025 · Dec 31, 2024 252.96K sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$2.69M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$4.12M
Stockholders Equity FY 2025 · Dec 31, 2025 $5.38M
Stockholders Equity FY 2025 · Dec 31, 2024 $3.48M
Stockholders Equity FY 2025 · Dec 31, 2023 $2.91M
Current Liabilities FY 2025 · Dec 31, 2025 $418.59K
Current Liabilities FY 2025 · Dec 31, 2024 $377.71K
Total Liabilities FY 2025 · Dec 31, 2025 $418.59K
Total Liabilities FY 2025 · Dec 31, 2024 $377.71K
Current Assets FY 2025 · Dec 31, 2025 $5.8M
Current Assets FY 2025 · Dec 31, 2024 $3.86M
Total Assets FY 2025 · Dec 31, 2025 $5.8M
Total Assets FY 2025 · Dec 31, 2024 $3.86M
Eps Diluted FY 2025 · Dec 31, 2025 −$2.65
Eps Diluted restated FY 2025 · Dec 31, 2024 −$28.96
Eps Basic FY 2025 · Dec 31, 2025 −$2.65
Eps Basic restated FY 2025 · Dec 31, 2024 −$28.96
Sga Expense FY 2025 · Dec 31, 2025 $2.17M
Sga Expense FY 2025 · Dec 31, 2024 $2.09M
Rd Expense FY 2025 · Dec 31, 2025 $1.06M
Rd Expense FY 2025 · Dec 31, 2024 $2.13M
Net Income FY 2025 · Dec 31, 2025 −$3.11M
Net Income FY 2025 · Dec 31, 2024 −$4.11M
Operating Income FY 2025 · Dec 31, 2025 −$3.23M
Operating Income FY 2025 · Dec 31, 2024 −$4.22M